Introduction
Battery-operated pacemakers were developed to treat bradycardia in 1958, and implantable cardioverterdefibrillators (ICDs) to treat tachyarrhythmias followed in 1980. ICD advancements have three important results. First, all ICDs have brady-pacing capability, and the presence of pacing artifacts on an ECG might lead a practitioner to mistake an ICD for a (non-ICD) pacemaker. If ECGs are routinely collected from patients with 'pacemakers' using a magnet, then some ICDs from Guidant/CPI might be permanently deactivated with magnet placement [1] . Second, ICD brady-pacing is never converted to asynchronous mode with magnet placement. Third, ICDs respond to, and process, electromagnetic interference (EMI) differently than a pacemaker.
The complexity of cardiac generators limits generalizations that can be made about the perioperative care of these patients. Population aging, continued enhancements, and new indications for implantation of cardiac devices will lead to increased implantations. Whether pacemaker or ICD patients have increased perioperative morbidity/mortality remains an area ripe for investigation. Levine et al. reported increases in pacing thresholds in some thoracic operations [2] . In 1995, Badrinath et al. retrospectively reviewed ophthalmic surgery cases in one hospital in Madras, India from 1979 through 1988 (14 787 cases) and reported that the presence of a pacemaker significantly increased the probability of a mortal event within 6 weeks postoperatively, regardless of the anesthetic technique [3] . In abstract form, Samain et al. reported that three of 73 pacemaker patients (4.1%) undergoing significant surgery (not including open-heart surgery) died postoperatively of cardiac cause, although a time-frame was not specified [4] . Also in abstract form, Rozner et al. reported preop to postop pacing threshold increases in nonthoracic surgery [5] . These issues led the American Society of Anesthesiologists to publish a Practice Advisory for these patients [6] . Other guidelines have been published as well [7] [8] [9] [10] , although not all authors recommend ICD disablement in the perioperative period [11] . ICDs also perform permanent cardiac pacing, so ICD issues related primarily to antibrady pacing should be reviewed in the Pacing section. Table 1 shows perioperative guidelines adapted from a number of sources.
Also, some generator manufacturers have issued a variety of notices regarding potential failures in both pacemakers [12] [13] [14] and ICDs [15] [16] [17] . For some ICDs, Guidant has found that 45 000 devices are at risk for improperly entering the 'magnet mode', which prevents any detection (and, therefore, treatment) of tachyarrhythmias. As a 'work-around', Guidant has recommended the permanent disabling of the magnet mode through programming [18] . Although pacemakers and ICDs are more reliable than almost any other technology, some devices fail prematurely. Using data from the FDA, Maisel et al. reported that for every 1000 implants, 1.4 pacemaker and 36.4 ICD patients underwent device explanation for unexpected device failure during 2001-2002 [19 ] .
These systems consist of an impulse generator and lead(s). Leads can have one (unipolar), two (bipolar), or multiple (multipolar) electrodes with connections in multiple chambers. In unipolar pacing, as well as defibrillation, the generator case serves as an electrode, and tissue contact in a pacemaker has been disrupted by pocket gas [20] . Pacing in a unipolar mode (unusual in an ICD system) produces larger 'spikes' on an analoguerecorded ECG, and unipolar sensing is more sensitive to EMI. Most pacemaking systems use bipolar pacing/ sensing configuration, since bipolar pacing usually requires less energy and bipolar sensing is more resistant to interference from muscle artifacts or stray electromagnetic fields. Often, bipolar electrodes can be identified on the chest film since they will have a ring electrode 1-3 cm proximal to the lead tip. ICDs can be distinguished from conventional pacemakers by the presence of a shock coil on the right ventricular lead ( Fig. 1 ).
Finally, devices resembling cardiac pulse generators are being implanted at increasing rates for pain control, thalamic stimulation to control Parkinson's disease, phrenic nerve stimulation to stimulate the diaphragm in paralyzed patients, and vagus nerve stimulation to control epilepsy and possibly obesity [21] . These devices can be confused for a cardiac generator as well.
For ease of reading, this review is divided into a section on conventional pacemakers and a section on ICDs.
Pacemaker overview
The Pacemaking Code of the North American Society of Pacing and Electrophysiology (NASPE) and the British Pacing and Electrophysiology Group (BPEG) describes basic pacing behavior Table 2 [22] . Single chamber pacemakers can pace the atrium (AAI) or the ventricle (VVI) Dual chamber programming (DDD) is used to provide atrio-ventricular synchrony; VDD pacing (single wire device providing atrio-ventricular synchrony) can be found in patients with atrio-ventricular nodal disease but normal sinus node function. Some patients with atrial dysrhythmias have DDI programming (atrio-ventricular synchrony is provided only when the pacemaker provides atrial pacing). Biatrial pacing is being investigated as a means to prevent atrial fibrillation [23] , and biventricular pacing [also called Cardiac Resynchronization Therapy (CRT)] is used to treat dilated cardiomyopathy [24] [25] [26] .
Permanent pacing indications (Table 3 ) are reviewed in detail elsewhere [27] . In order to be effective, pacing for CRT, hypertrophic cardiomyopathy, and dilated cardiomyopathy must provide the stimulus for ventricular activation, and atrio-ventricular synchrony must be preserved [28] . Pacemaker inhibition, loss of pacing (i.e. from native conduction, junctional rhythm, EMI), or atrio-ventricular dys-synchrony can lead to deteriorating hemodynamics in these patients. Biventricular pacing can lengthen the Q-T interval in some patients, producing torsade-de-pointes [29] . Thus access to rapid defibrillation is required for the patient with biventricular pacing. is better than 'blend' or 'coag' Place the ESU current return pad in such a way to prevent electricity from crossing the generator-heart circuit, even if the pad must be placed on the distal forearm and the wire covered with sterile drape If the ESU causes ventricular oversensing, pacer quiescence, or tachycardia, limit the period(s) of asystole or reprogram the device Postoperative key points Have the device interrogated by a competent authority postop. Some rate enhancements can be re-initiated and optimum heart rate and pacing parameters should be determined. The ICD patient must be monitored until the antitachycardia therapy is restored ESU, electrosurgery; ICD, implantable cardioverter-defibrillator.
Pacemaker magnets
Despite oft-repeated folklore, as well as 'conventional wisdom', magnets were never intended to treat pacemaker emergencies or prevent EMI effects. Rather, magnet-activated switches were incorporated into pacemakers to produce pacing behavior that demonstrates remaining battery life and, sometimes, pacing threshold safety factors. Placement of a magnet over a generator might produce no change in pacing since not all pacemakers have continuous, asynchronous modes. Also, not all models from a given company behave the same way. Effect(s) of magnet placement are shown in Table 4 . Calling the manufacturer remains the most reliable method for determining available magnet responses and using this response to predict remaining battery life. Since magnet behavior can be altered or disabled via programming in some devices (Biotronik, CPI, Guidant Medical, Pacesetter, St Jude Medical), only an interrogation with a programmer can reveal current settings. A complete table of magnet responses has been published [30] .
Preanesthetic evaluation and pacemaker reprogramming
Preoperative management of the patient with a pacemaker includes evaluation and optimization of coexisting disease(s). No special laboratory tests or radiographs are needed for the patient with a conventional pacemaker. A patient with a biventricular pacer (or ICD) might need a chest film to document the position of the coronary sinus lead, especially if central line placement is planned, since spontaneous coronary sinus lead dislodgement can occur [31, 32] .
Important features of the preanesthetic device evaluation are shown in Table 1 . Current NASPE and Medicare guidelines include telephonic (magnet) evaluation every 4-12 weeks (depending upon device type and age) and a comprehensive device interrogation with a programmer at least once per year [33] .
Direct interrogation with a programmer remains the only reliable method for evaluating battery status, lead performance, and adequacy of current settings. Some devices retain pacing histograms and information about tachydysrhythmia(s). Appropriate reprogramming (Table 5 ) is the safest way to avoid intraoperative problems, especially if monopolar 'Bovie' electrosurgery will be used. The pacemaker manufacturers stand ready to assist with this task; however, any industry-employed allied professional (i.e., the 'rep') should be supervised by an appropriately trained physician [34] . Reprogramming the pacemaker to asynchronous pacing at a rate greater than the patient's underlying rate usually ensures that no oversensing or undersensing from EMI will take place. Setting a device to asynchronous mode, however, Cardiac pacemaker or implanted defibrillator management Rozner 263
Figure 1 A defibrillator system with biventricular antibradycardia pacemaker capability
This chest film was taken from a 78-year-old man with right upper lobe lung cancer, coronary artery disease, and ischemic cardiomyopathy with ejection fraction of 22%. The implantable cardioverter-defibrillator (ICD) generator is in the left pectoral position with three leads: a conventional, bipolar lead to the right atrium, a tripolar lead to the right ventricle (RV), and a unipolar lead to the coronary sinus (CS). This system is designed to provide 'resynchronization (antibradycardia) therapy' in the setting of a dilated cardiomyopathy with a prolonged QRS (and frequently with a prolonged P-R interval as well). The bipolar lead in the right atrium will perform both sensing and pacing function. In the RV, the tip electrode functions as the cathode for pacing and sensing functions. The presence of a 'shock' conductor (termed 'shock coil') on the RV lead in the right ventricle distinguishes a defibrillation system from a conventional pacemaking system. In this particular patient, the RV shock coil also functions as the pacing and sensing anode (this is called an integrated bipolar defibrillator lead; true bipolar leads have a ring electrode between the tip electrode and the shock coil). The lead in the coronary sinus depolarizes the left ventricle, and the typical current pathway includes the anode in the right ventricle. Due to the typically wide QRS complex in a left bundle branch pattern, failure to capture the left ventricle can lead to ventricular oversensing (and inappropriate antitachycardia therapy) in an ICD system. Many defibrillation systems (including this one) also have a shock coil in the superior vena cava, which is electrically identical to the defibrillator case (called the 'can'). When the defibrillation circuit includes the ICD case, it is called 'active can configuration'. has the potential to create a malignant rhythm in the patient with structurally compromised myocardium [35] .
Reprogramming a device will not protect it from internal damage or reset caused by EMI. In general, rate responsiveness and 'enhancements' (dynamic atrial overdrive, hysteresis, sleep rate, A-V search, etc.) should be disabled by programming, since many of these features can mimic pacing dysfunction [7, 36, 37] . It should be noted that for many Guidant and/or CPI devices, Guidant Medical recommends increasing the pacing voltage to '5 volts or higher' when monopolar electrosurgery will be used. Few cardiologists follow this recommendation, but there are reports of threshold changes during both intrathoracic [2] and nonchest surgery [38] . Recently, pacing threshold was shown to be increased by disease states [39] . Special attention must be given to any device with a minute ventilation (bioimpedance) sensor (Table 6 ) since inappropriate tachycardia has been observed secondary to mechanical ventilation [40, 41] , monopolar ('Bovie') electrosurgery [40, 42, 43] , and connection to an ECG monitor with respiratory rate monitoring [39, [44] [45] [46] [47] [48] . Sometimes, inappropriate therapy producing life-threatening results has been delivered in these settings [41, 49 ] .
Intraoperative (or procedure) management of pacemakers
No special technique or monitoring is needed for the pacemaker patient, but attention must be given to a number of concerns (Table 7) . Monopolar 'Bovie' electrosurgery use remains the principal intraoperative issue for the patient with a pacemaker. Between 1984 and 1997, the US FDA was notified of 456 adverse events with pulse generators, 255 from electrosurgery, and a 'significant number' of device failures [50] . Coagulation electrosurgery is more likely to cause problems than cutting electrosurgery [51] . Magnet placement during electrosurgery might prevent aberrant pacemaker (but not ICD) behavior, and spurious reprogramming with magnet 264 Anaesthesia and medical disease For CPI/Guidant ICDs, if magnet mode is programmed to 'ON', appropriate magnet placement immediately disables tachy detection and therapy, and tachy therapies remain disabled for as long as the magnet remains appropriately applied. If each heartbeat produces a 'beep', then the device will be enabled for tachy therapy upon magnet removal. If the device emits a constant tone, then tachy therapy is disabled whether or not a magnet is present. If the 'Change Tachy Mode with Magnet' feature also is programmed 'ON', after 30 s of continuous magnet application, the tachy mode changes, i.e., it will switch from enabled (in absence of magnet, beeping) to permanently disabled (constant tone) or vice versa. Any CPI/Guidant ICD that does not emit sound when a magnet is applied should undergo an immediate device interrogation. placement is unlikely. If monopolar electrosurgery is to be used, then the electrosurgery current-return pad must be placed to ensure that electrosurgery current path does not cross the chest or the pacemaking system. Some authors recommend placement of this pad on the shoulder for head and neck procedures or the distal arm (with sterile draping of the wire) for breast and axillary procedures when the generator is ipsilateral to the surgical site [51, 53] .
Choice of anesthetic agents should be dictated primarily by the patient's underlying physiology as well as the procedure. The use of drugs that suppress the atrioventricular or SA node (such as potent opiates or dexmedetomidine), however, can abolish any underlying rhythm that might be present and render the patient truly pacing-dependent. Also, some potent inhalational agents (isoflurane, sevoflurane, and desflurane) may exacerbate the long Q-T syndrome [54] [55] [56] [57] .
Finally, attention must be given to the electrocardiographic monitor. Most monitors have high-frequency filtering that removes the pacemaker artifact, and many of the monitors can be fooled by the electrosurgery or the nerve stimulator [58] . The monitors frequently report inappropriate heart rates on the electrocardiographic channel. As a result, the pulse must be measured mechanically. Methods for such measurement include pulse oximeter or noninvasive pressure plethysmography, invasive pressure monitor, or Doppler waveforms.
Pacemaker failure
Pacemaker failure has three etiologies: first, failure to capture; second, lead failure; or third, generator failure. Failure to capture can result from myocardial ischemia/ infarction, acid-base disturbance, electrolyte abnormalities, or abnormal antiarrhythmic drug level(s). External pacing can further inhibit permanent pacemaker output due to oversensing of the temporary pacing pulse by the permanent pacemaker, even at temporary pacing energies that do not produce myocardial capture [59, 60] . Sympathomimetic drugs generally lower pacing threshold. Outright generator and/or lead failure is rare in an appropriately tested system.
Postoperative pacemaker evaluation
Any pacemaker that was reprogrammed for the operating room should be reset appropriately. For nonreprogrammed devices, most manufacturers recommend interrogation to ensure proper functioning and remaining battery life if any electrosurgery was used. Attention should be paid to possible perioperative changes in pacing or sensing thresholds, and an appropriate lower pacing rate should be chosen to ensure appropriate delivery of oxygen to the tissues.
Implantable cardioverter-defibrillator overview
For the patient with ventricular tachycardia or fibrillation, ICDs clearly reduce deaths, and they remain superior to antiarrhythmic drug therapy [61] . Further, studies such as the Multicenter Automatic Defibrillator Implantation Trial II (ischemic cardiomyopathy, ejection fraction less than 0.30 [62] ) and the Sudden Cardiac Death -Heart Failure Trial (any cardiomyopathy, ejection fraction less than 0.35 [63] ) have demonstrated that placement of ICDs in patients (without evidence of tachyarrhythmias) reduces overall cardiac mortality, thus increasing the number of patients for whom ICD therapy is indicated. Table 8 shows current ICD indications.
Like pacemakers, ICDs have a four-place code (Table 9 ) [64] . The Pacemaker Code can be used instead of Cardiac pacemaker or implanted defibrillator management Rozner 265 Position IV. Current follow-up guidelines suggest a comprehensive device interrogation with a programmer every 3-4 months.
ICDs measure each cardiac R-R interval and categorize the rate as normal, too fast (short R-R interval), or too slow (long R-R interval). When enough short R-R intervals are detected, an antitachycardia event is begun. The internal computer chooses antitachycardia pacing (ATP, less energy use, better tolerated by patient) or shock, depending upon the presentation and device programming. Most ICDs are programmed to 'reconfirm' ventricular tachycardia or ventricular fibrillation after charging to prevent inappropriate therapy. Typically, ICDs deliver 6-18 shocks per event. Once a shock is delivered, no further ATP can take place. Despite improvements in detection of ventricular dysrhythmias [65] , more than 10% of shocks are for rhythm other than ventricular tachycardia or ventricular fibrillation [66] . Whether inappropriate shocks injure patients remains a subject of considerable debate, but many patients who receive an inappropriate shock will demonstrate elevated troponin levels in the absence of an ischemic event [67] .
Supraventricular tachycardia remains the most common etiology of inappropriate shock therapy, and causes of inappropriate shock have been reviewed elsewhere [68] . Most ICDs will begin pacing when the R-R interval is too long. ICDs with sophisticated, dual and three-chamber pacing modes (including rate responsiveness) are approved for patients who need permanent pacing (about 20% of ICD patients). It should be noted that the use of dual chamber (DDD) pacing in an ICD patient might decrease survival when compared with single chamber (VVI) pacing [69] .
Also, an inappropriate shock (i.e., no arrhythmia present) can be delivered without prior ECG changes if a lead is damaged or defective, resulting from electrical 'chatter' [70] . Currently, several ventricle leads are on 'alert status' for such false signal generation. Table 4 shows the usual (default) behavior for appropriate magnet placement in many ICDs.
Preanesthetic evaluation and implantable cardioverter-defibrillator reprogramming
In addition to evaluating and optimizing comorbid disease(s), every ICD patient should undergo preoperative ICD interrogation. Magnet nonresponsiveness should be identified in this visit. Important features of the preanesthetic device evaluation are shown in Table 1 .
All ICD patients should have antitachycardia therapy disabled if monopolar Bovie use is planned, or if there is evidence of lead problems [6, 7] . In situations where lead performance is adequate and no monopolar Bovie will be used, magnet placement on a magnetresponsive device (or tachy therapy disablement by programming) might be indicated in any case wherein patient movement could produce disastrous results (such as intra-ocular surgery). The comments in the pacing section apply here for antibradycardia pacing.
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No special monitoring or anesthetic technique (due to the ICD) is required for the ICD patient. ECG monitoring and the ability to deliver external cardioversion or defibrillation must be present during the time of ICD disablement. If emergency cardioversion or defibrillation is needed, the defibrillator pads should be placed to avoid the pulse generator to the extent possible. Nevertheless, one should remember that the patient, not the ICD, is being treated. The recommendations in the section 'Intraoperative (or procedure) management of pacemakers' also apply here. ICDs should be disabled prior to insertion of a central line to prevent inappropriate shock and possible ICD failure [71] .
Postoperative implantable cardioverter-defibrillator evaluation
The ICD must be reinterrogated and re-enabled, and pacing parameters should be checked and reset as necessary, as discussed in the pacing section. Any recorded tachycardia events should be reviewed and counters should be cleared.
Conclusion
Electronic miniaturization of pacemakers and ICDs has permitted the design and use of sophisticated electronics in patients who have need for artificial pacing and/or automated cardioversion/defibrillation of their heart. These devices are no longer confined to keeping the heart beating between a minimum rate (pacing function) and a maximum rate (ICD functions), as they are being used as therapy to improve the failing heart. The aging of the population and our ability to care for a patient with increasingly complex disease suggest that we will be caring for many more patients with these devices, and we must be prepared for this situation. Safe and efficient clinical management of these patients depends upon our understanding of implantable systems, indications for their use, and the perioperative needs that they create.
